ask="74.25"
ask_size="200"
average_daily_volume="565916"
bid="N/A"
bid_size="N/A"
book_value="11.38"
change="-1.20"
change_from_200_day_moving_average="0.21"
change_from_50_day_moving_average="-3.00"
change_from_52_week_high="-18.11"
change_From_52_week_low="22.14"
change_in_percent="-1.72%"
close="68.66"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-5.88"
ebitda="-230.87M"
eps_estimate_current_year="-6.14"
eps_estimate_next_quarter="-1.68"
eps_estimate_next_year="-6.72"
ex_dividend_date="N/A"
float_shares="37661000"
high="70.81"
high_52_weeks="86.77"
last_trade_date="1/26/2017"
last_trade_price="68.66"
last_trade_size="20023"
last_trade_time="4:00pm"
low="68.21"
low_52_weeks="46.52"
market_capitalization="2.81B"
moving_average_200_day="68.45"
moving_average_50_day="71.66"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="92.73"
open="69.89"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+0.30%"
percent_change_from_50_day_moving_average="-4.19%"
percent_change_from_52_week_high="-20.87%"
percent_change_from_52_week_low="+47.59%"
previous_close="69.86"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.14"
price_per_sales="22300.08"
revenue="128000.00"
shares_outstanding="40859000"
short_ratio="10.26"
stock_exchange="NMS"
symbol="RARE"
volume="219064"
weeks_range_52="46.52 - 86.77"
